2Bonadonna G,Valagussa P,Moliterni A,et al.Adjuvant cyclophosphanide,methotrexate,and fluorouracil in node-positive breast cancer:the results of 20 years of follow-up[J].N Engl J Med,1995,332(14):901-906.
3Rose C,Andersen JA,Andersen KW,et al.Adjuvant endocrine treatment of postmenopausal patients with breast cancer with high risk of recurrence.5.Resultsfrom the DBCG(Danish Breast Cancer Cooperative Group) 77c randomized Trial[J].Ugeskr Laeger,1991,153(33):2283-2287.
4Fisher B,Redmond C,Legault-Poisson S,et al.Postoperative chemotherapy and tamoxilen compared with tamoxilen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen:results from the national surgical adjuvant breast and bowel project B-16[J].J Clin Oncol,1990,8(6):1005-1018.
5Fisher B,Dignam J,Wolmark N,et al.Tanoxifen and chemotherapy for lymph node-negative,estrogen receptor-positive breast cancer[J].J Natl Cancer Inst,1997,89(22):1673-1682.
6Early Breast Cancer Trialists Collaborative Group.Systemic treatment of early breast cancer by hormonal,cytotoxic or immune therapy[J].Lancet,1992,339(8785):1-15.
